19 January 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics reports that biosimilars are the next generation of drugs for liver and gastrointestinal diseases.
A biosimilar is a copy version of an approved original biological medicine whose data protection
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors